Cardiovascular and Pulmonary Manifestations of Systemic Lupus Erythematosus.
Tselios K, Urowitz MB.
Curr Rheumatol Rev. 2017;13(3):206-218. doi: 10.2174/1573397113666170704102444.
Advances in Understanding of Pathogenesis and Treatment of Immune-Mediated Kidney Disease: A Review.
Kant S, Kronbichler A, Sharma P, Geetha D.
Am J Kidney Dis. 2022 Apr;79(4):582-600. doi: 10.1053/j.ajkd.2021.07.019. Epub 2021 Sep 8.
Interorgan communication networks in the kidney-lung axis.
Komaru Y, Bai YZ, Kreisel D, Herrlich A.
Nat Rev Nephrol. 2024 Feb;20(2):120-136. doi: 10.1038/s41581-023-00760-7. Epub 2023 Sep 4.
Molecules Great and Small: The Complement System.
Mathern DR, Heeger PS.
Clin J Am Soc Nephrol. 2015 Sep 4;10(9):1636-50. doi: 10.2215/CJN.06230614. Epub 2015 Jan 7.
The genus Aeromonas: taxonomy, pathogenicity, and infection.
Janda JM, Abbott SL.
Clin Microbiol Rev. 2010 Jan;23(1):35-73. doi: 10.1128/CMR.00039-09.
Uremic lung.
Grassi V, Malerba M, Boni E, Tantucci C, Sorbini CA.
Contrib Nephrol. 1994;106:36-42. doi: 10.1159/000422922.
Uremic lung: The "calcified cauliflower" sign in the end stage renal disease.
Dilorenzo G, Telegrafo M, Marano G, De Ceglie M, Stabile Ianora AA, Angelelli G, Moschetta M.
Respir Med Case Rep. 2016 Oct 6;19:159-161. doi: 10.1016/j.rmcr.2016.10.003. eCollection 2016.
Therapeutic Targeting of the Complement System: From Rare Diseases to Pandemics.
Garred P, Tenner AJ, Mollnes TE.
Pharmacol Rev. 2021 Apr;73(2):792-827. doi: 10.1124/pharmrev.120.000072.
Renal-pulmonary crosstalk.
Singbartl K.
Contrib Nephrol. 2011;174:65-70. doi: 10.1159/000329237. Epub 2011 Sep 9.
Cardiovascular Consequences of Uremic Metabolites: an Overview of the Involved Signaling Pathways.
Curaj A, Vanholder R, Loscalzo J, Quach K, Wu Z, Jankowski V, Jankowski J.
Circ Res. 2024 Mar;134(5):592-613. doi: 10.1161/CIRCRESAHA.123.324001. Epub 2024 Feb 29.
